Cerus Quick Ratio (CERS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Cerus Corporation  (NASDAQ: CERS)

Cerus's Quick Ratio

CERS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.21 a new company low.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Quick Ratio than Cerus in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 2264, from total ranking in the first quarter 2026 at 2676.

Explain Quick Ratio?
How much Cash & cash equivalents CERS´s has?
What are CERS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CERS Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 1.7 % 54.09 % 58.47 % 62.73 % 56.55 %
Y / Y Cash & cash equivalent Change -76.96 % -0.61 % 3.02 % 3.9 % 9.59 %
Quick Ratio MRQ 0.21 0.75 0.82 0.89 0.92
CERS's Total Ranking # 2264 # 2676 # 2411 # 2445 # 2192
Seq. Current Liabilities Change -20.11 % 6.53 % 13.99 % 4.83 % 21.05 %
Seq. Cash & cash equivalent Change -77.64 % -2.96 % 5.56 % 0.62 % -3.58 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 172
Healthcare Sector # 819
Overall Market # 3352


Quick Ratio Statistics
High Average Low
7.36 2.25 0.21
(Mar 31 2013)   (Jun 30 2026)




Financial Statements
Cerus's Current Liabilities $ 86 Millions Visit CERS's Balance sheet
Cerus's Cash & cash equivalent $ 18 Millions Visit CERS's Balance sheet
Source of CERS's Sales Visit CERS's Sales by Geography


Cumulative Cerus's Quick Ratio

CERS's Quick Ratio for the trailling 12 Months

CERS Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 40.59 % 57.74 % 49.85 % 31.37 % 5.11 %
Y / Y Cash & cash equivalent TTM Growth -17.51 % 3.8 % 7 % 11.63 % 9.27 %
Quick Ratio TTM 0.68 0.84 0.93 1.04 1.16
Total Ranking TTM # 2808 # 3264 # 2400 # 2279 # 2245
Seq. Current Liabilities TTM Growth 0.38 % 10.98 % 12.15 % 12.53 % 12.62 %
Seq. Cash & cash equivalent TTM Growth -18.77 % -0.15 % 0.76 % 0.94 % 2.22 %

Quick ratio ranking by company, industry and sector >> Back to CERS Financial Strength Comparisons >> Go to Compare CERS Quick Ratio to its Competitors

On the trailing twelve months basis Due to decline in Current Liabilities in the Q2 2026 to $85.79 millions, cumulative Quick Ratio decreased to 0.68 below the Cerus Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Cerus. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3881.

Explain Quick Ratio?
How much Cash & cash equivalents CERS´s has?
What are CERS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 908
Within the Market # 2264


trailing twelve months Quick Ratio Statistics
High Average Low
2.05 0.76 0.21
(Mar 31 2016)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Invo Fertility Inc   0.57 $ 3.733  Millions$ 6.520  Millions
Align Technology inc   0.55 $ 1,102.591  Millions$ 1,999.055  Millions
Interpace Biosciences Inc   0.54 $ 2.688  Millions$ 4.951  Millions
FAMILY OFFICE OF AMERICA, INC.  0.53 $ 0.637  Millions$ 1.208  Millions
Stryker Corp  0.52 $ 3,507.000  Millions$ 6,684.000  Millions
Embecta Corp   0.51 $ 214.700  Millions$ 419.800  Millions
Milestone Scientific Inc   0.51 $ 2.067  Millions$ 4.043  Millions
Strata Critical Medical Inc   0.50 $ 23.017  Millions$ 45.779  Millions
Alphatec Holdings Inc   0.50 $ 118.662  Millions$ 237.966  Millions
Teleflex Incorporated  0.45 $ 326.602  Millions$ 720.379  Millions
Novocure Limited  0.45 $ 99.287  Millions$ 220.710  Millions
Ss Innovations International Inc  0.43 $ 13.647  Millions$ 31.892  Millions
Stereotaxis Inc   0.42 $ 11.218  Millions$ 26.797  Millions
Glucotrack Inc   0.38 $ 1.124  Millions$ 2.988  Millions
Steris Plc  0.38 $ 482.300  Millions$ 1,283.300  Millions
Lakeland Industries Inc   0.37 $ 17.100  Millions$ 45.876  Millions
Femasys Inc   0.37 $ 1.444  Millions$ 3.887  Millions
Docgo Inc   0.37 $ 26.569  Millions$ 72.334  Millions
Sanuwave Health Inc   0.36 $ 9.376  Millions$ 25.723  Millions
Iridex Corp  0.36 $ 4.680  Millions$ 13.173  Millions
Heartsciences Inc   0.34 $ 1.657  Millions$ 4.861  Millions
Cadre Holdings inc   0.29 $ 53.984  Millions$ 187.734  Millions
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions

Date modified: 2026-09-14T03:49:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.